Assessing anthracycline‐treated childhood cancer survivors with advanced stress echocardiography. Issue 3 (12th November 2014)
- Record Type:
- Journal Article
- Title:
- Assessing anthracycline‐treated childhood cancer survivors with advanced stress echocardiography. Issue 3 (12th November 2014)
- Main Title:
- Assessing anthracycline‐treated childhood cancer survivors with advanced stress echocardiography
- Authors:
- Ryerson, A. Blythe
Border, William L.
Wasilewski‐Masker, Karen
Goodman, Michael
Meacham, Lillian
Austin, Harland
Mertens, Ann C. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25328-sec-0001" sec-type="section"> <title>Background</title> <p>Surveillance for anthracycline cardiotoxicity in cancer survivors typically utilizes resting M‐mode and two‐dimensional echocardiography, which are insensitive to detection of subtle myocardial changes. We examined childhood cancer survivors treated with anthracyclines during exercise using various echocardiography techniques to investigate if these tools can better detect subclinical cardiac dysfunction.</p> </sec> <sec id="pbc25328-sec-0002" sec-type="section"> <title>Procedure</title> <p>We recruited asymptomatic survivors at least five years post treatment. Echocardiography was performed at rest and at termination of exercise utilizing tissue Doppler techniques and strain rate imaging.</p> </sec> <sec id="pbc25328-sec-0003" sec-type="section"> <title>Results</title> <p>Eighty participants were characterized by cardiotoxicity risk status (high [12], moderate [23], low [24], no risk [21]) as defined by the Children's Oncology Group Long Term Follow‐Up Guidelines v3.0. The high‐risk group had a higher resting heart rate than controls (100 vs. 88 bpm [<italic>P</italic> for trend = 0.049]). Peak aerobic capacity in all groups was similar. Compared to controls at rest, the high‐risk group had evidence of diastolic dysfunction with lower E/A ratios (1.4 vs. 2.0, <italic>P</italic> = 0.008) and higher<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25328-sec-0001" sec-type="section"> <title>Background</title> <p>Surveillance for anthracycline cardiotoxicity in cancer survivors typically utilizes resting M‐mode and two‐dimensional echocardiography, which are insensitive to detection of subtle myocardial changes. We examined childhood cancer survivors treated with anthracyclines during exercise using various echocardiography techniques to investigate if these tools can better detect subclinical cardiac dysfunction.</p> </sec> <sec id="pbc25328-sec-0002" sec-type="section"> <title>Procedure</title> <p>We recruited asymptomatic survivors at least five years post treatment. Echocardiography was performed at rest and at termination of exercise utilizing tissue Doppler techniques and strain rate imaging.</p> </sec> <sec id="pbc25328-sec-0003" sec-type="section"> <title>Results</title> <p>Eighty participants were characterized by cardiotoxicity risk status (high [12], moderate [23], low [24], no risk [21]) as defined by the Children's Oncology Group Long Term Follow‐Up Guidelines v3.0. The high‐risk group had a higher resting heart rate than controls (100 vs. 88 bpm [<italic>P</italic> for trend = 0.049]). Peak aerobic capacity in all groups was similar. Compared to controls at rest, the high‐risk group had evidence of diastolic dysfunction with lower E/A ratios (1.4 vs. 2.0, <italic>P</italic> = 0.008) and higher septal early diastolic velocities (E/E') of 11.7 versus 9.9 (<italic>P </italic>= 0.165). With exercise, this difference resolved and myocardial contractile reserve was preserved.</p> </sec> <sec id="pbc25328-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Asymptomatic, pediatric cancer survivors at high‐risk for anthracycline cardiotoxicity have some evidence of diastolic filling abnormalities at rest. With exercise, they augment their systolic and diastolic function to achieve normal maximal aerobic capacity suggesting they are able to compensate for mild cardiac dysfunction in the early years after exposure. Additionally, findings suggest that routine exercise echocardiography may not be a useful surveillance tool to assess anthracycline cardiotoxicity. Pediatr Blood Cancer 2015;62:502–508. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Pediatric blood & cancer. Volume 62:Issue 3(2015:Mar.)
- Journal:
- Pediatric blood & cancer
- Issue:
- Volume 62:Issue 3(2015:Mar.)
- Issue Display:
- Volume 62, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 62
- Issue:
- 3
- Issue Sort Value:
- 2015-0062-0003-0000
- Page Start:
- 502
- Page End:
- 508
- Publication Date:
- 2014-11-12
- Subjects:
- Tumors in children -- Periodicals
Blood -- Diseases -- Periodicals
Cancer in children -- Periodicals
618.92 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1545-5017 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pbc.25328 ↗
- Languages:
- English
- ISSNs:
- 1545-5009
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6417.533500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4393.xml